Shailendra P Singh1, Joseph Schragenheim1, Jian Cao2, John R Falck3, Nader G Abraham4, Lars Bellner5. 1. Department of Pharmacology, New York Medical College, Valhalla, NY 10595, United States. 2. First Geriatric Cardiology Division, Chinese PLA General Hospital, Beijing, China. 3. Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States. 4. Department of Pharmacology, New York Medical College, Valhalla, NY 10595, United States; Department of Medicine, New York Medical College, Valhalla, NY 10595, United States; Department of Medicine, Marshall University, Joan C. Edwards School of Medicine, Huntington, WV 25701, United States. Electronic address: Nader_Abraham@nymc.edu. 5. Department of Pharmacology, New York Medical College, Valhalla, NY 10595, United States. Electronic address: Lars_bellner@nymc.edu.
Abstract
BACKGROUND/ OBJECTIVES: Obesity is a risk factor in the development of type 2 diabetes mellitus (DM2), which is associated with increased morbidity and mortality, predominantly as a result of cardiovascular complications. Increased adiposity is a systemic condition characterized by increased oxidative stress (ROS), increased inflammation, inhibition of anti-oxidant genes such as HO-1 and increased degradation of epoxyeicosatrienoic acids (EETs). We previously demonstrated that EETs attenuate mitochondrial ROS. We postulate that EETs increase peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), which controls mitochondrial function, oxidative metabolism and induction of HO-1. METHODS: Cultured murine adipocytes and mice fed a high fat (HF) diet were used to assess functional relationship between EETs, HO-1 and (PGC-1α) using an EET analogue (EET-A) and lentivirus to knock down the PPARGC1A gene. RESULTS: EET-A increased PGC-1α and HO-1 in cultured adipocytes and increased the expression of genes involved in thermogenesis and adipocyte browning (UCP1 and PRDM16, respectively). PGC-1α knockdown prevented EET-A-induced HO-1expression, suggesting that PGC-1α is upstream of HO-1. MRI data obtained from fat tissues showed that EET-A administration to mice on a HF diet significantly reduced total body fat content, subcutaneous and visceral fat deposits and reduced the VAT: SAT ratio. Moreover EET-A normalized the VO2 and RQ (VCO2/VO2) in mice fed a HF diet, an effect that was completely prevented in PGC-1α deficient mice. In addition, EET-A increased mitochondrial biogenesis and function as measured by OPA1, MnSOD, Mfn1, Mfn2, and SIRT3, an effect that was inhibited by knockdown of PGC-1α. CONCLUSION: Taken together, our findings show that EET-A increased PGC-1α thereby increasing mitochondrial viability, increased fusion potential thereby providing metabolic protection and increased VO2 consumption in HF-induced obesity in mice, thus demonstrating that the EET-mediated increase in HO-1 levels require PGC-1α expression.
BACKGROUND/ OBJECTIVES:Obesity is a risk factor in the development of type 2 diabetes mellitus (DM2), which is associated with increased morbidity and mortality, predominantly as a result of cardiovascular complications. Increased adiposity is a systemic condition characterized by increased oxidative stress (ROS), increased inflammation, inhibition of anti-oxidant genes such as HO-1 and increased degradation of epoxyeicosatrienoic acids (EETs). We previously demonstrated that EETs attenuate mitochondrial ROS. We postulate that EETs increase peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), which controls mitochondrial function, oxidative metabolism and induction of HO-1. METHODS: Cultured murine adipocytes and mice fed a high fat (HF) diet were used to assess functional relationship between EETs, HO-1 and (PGC-1α) using an EET analogue (EET-A) and lentivirus to knock down the PPARGC1A gene. RESULTS:EET-A increased PGC-1α and HO-1 in cultured adipocytes and increased the expression of genes involved in thermogenesis and adipocyte browning (UCP1 and PRDM16, respectively). PGC-1α knockdown prevented EET-A-induced HO-1expression, suggesting that PGC-1α is upstream of HO-1. MRI data obtained from fat tissues showed that EET-A administration to mice on a HF diet significantly reduced total body fat content, subcutaneous and visceral fat deposits and reduced the VAT: SAT ratio. Moreover EET-A normalized the VO2 and RQ (VCO2/VO2) in mice fed a HF diet, an effect that was completely prevented in PGC-1α deficient mice. In addition, EET-A increased mitochondrial biogenesis and function as measured by OPA1, MnSOD, Mfn1, Mfn2, and SIRT3, an effect that was inhibited by knockdown of PGC-1α. CONCLUSION: Taken together, our findings show that EET-A increased PGC-1α thereby increasing mitochondrial viability, increased fusion potential thereby providing metabolic protection and increased VO2 consumption in HF-induced obesity in mice, thus demonstrating that the EET-mediated increase in HO-1 levels require PGC-1α expression.
Authors: Sandra Kleiner; Rina J Mepani; Dina Laznik; Li Ye; Michael J Jurczak; Francois R Jornayvaz; Jennifer L Estall; Diti Chatterjee Bhowmick; Gerald I Shulman; Bruce M Spiegelman Journal: Proc Natl Acad Sci U S A Date: 2012-05-29 Impact factor: 11.205
Authors: Knut H Lauritzen; Md Mahdi Hasan-Olive; Christine E Regnell; Liv Kleppa; Morten Scheibye-Knudsen; Albert Gjedde; Arne Klungland; Vilhelm A Bohr; Jon Storm-Mathisen; Linda H Bergersen Journal: Neurobiol Aging Date: 2016-08-18 Impact factor: 4.673
Authors: George S Drummond; Jeffrey Baum; Menachem Greenberg; David Lewis; Nader G Abraham Journal: Arch Biochem Biophys Date: 2019-08-16 Impact factor: 4.013
Authors: Joseph Schragenheim; Lars Bellner; Jian Cao; Shailendra P Singh; David Bamshad; John A McClung; Omri Maayan; Aliza Meissner; Ilana Grant; Charles T Stier; Nader G Abraham Journal: Prostaglandins Other Lipid Mediat Date: 2018-05-19 Impact factor: 3.072
Authors: Jian Cao; Shailendra P Singh; John A McClung; Gregory Joseph; Luca Vanella; Ignazio Barbagallo; Houli Jiang; John R Falck; Michael Arad; Joseph I Shapiro; Nader G Abraham Journal: Am J Physiol Heart Circ Physiol Date: 2017-06-02 Impact factor: 4.733
Authors: Lu Liu; Nitin Puri; Marco Raffaele; Joseph Schragenheim; Shailendra P Singh; J Alyce Bradbury; Lars Bellner; Luca Vanella; Darryl C Zeldin; Jian Cao; Nader G Abraham Journal: Prostaglandins Other Lipid Mediat Date: 2018-07-21 Impact factor: 3.072
Authors: Lars Bellner; Nachum B Lebovics; Rochelle Rubinstein; Yosef D Buchen; Emilia Sinatra; Giuseppe Sinatra; Nader G Abraham; John A McClung; Ellen A Thompson Journal: Antioxid Redox Signal Date: 2020-02-10 Impact factor: 8.401
Authors: Miguel A Ortega; Oscar Fraile-Martínez; Leonel Pekarek; Miguel A Alvarez-Mon; Ángel Asúnsolo; Lara Sanchez-Trujillo; Santiago Coca; Julia Buján; Melchor Álvarez-Mon; Natalio García-Honduvilla; Felipe Sainz Journal: Histol Histopathol Date: 2021-03-01 Impact factor: 2.303